covid-19 information Government

UNION therapeutics licences drug technology from TFF Pharmaceuticals

Reading now: 132
www.pharmaceutical-technology.com

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.UNION therapeutics has signed an agreement with TFF Pharmaceuticals for an exclusive global licence to the latter’s Thin Film Freezing (TFF) technology platform used with niclosamide drug.

The TFF platform is intended to improve the solubility and absorption of poorly water-soluble drugs, ideal for generating dry powder particles.

Under the deal, UNION will acquire an option to gain a licence to the TFF technology to be used with niclosamide, including oral and inhalation versions of the drug, potentially for Covid-19 treatment.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA